Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with...
HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind, multicenter, phase...
Kexing Biopharm Attended CPHI Worldwide 2023
SHENZHEN, China, Nov. 7, 2023 /PRNewswire/ -- Recently, CPHI Worldwide 2023 was successfully held in Barcelona, Spain. Kexing Biopharm exhibited more than ten kinds...
Trina Solar wins prestigious international design award for Vertex S+
CHANGZHOU, China, Nov. 7, 2023 /PRNewswire/ -- Trina Solar has won the 2024 German Design Award for its Vertex S n-type dual-glass rooftop PV module...
Digital Canvas Unleashed: 0010X0010 and Samsung Redefine Art
BANGKOK, Nov. 7, 2023 /PRNewswire/ -- "Algorithmic Organisms," a visionary exhibition by the Dutch/American A/V artist, 0010X0010, in collaboration with Samsung. This extraordinary showcase...
